Cargando…

Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study

Detalles Bibliográficos
Autores principales:	Painvin, Benoit, Guillot, Pauline, Verdier, Marie-Clémence, Gacouin, Arnaud, Maamar, Adel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276495/ https://www.ncbi.nlm.nih.gov/pubmed/32514594 http://dx.doi.org/10.1007/s00134-020-06142-y

Ejemplares similares

Pharmacocinétique de l’hydroxychloroquine chez les patients COVID-19 en réanimation : étude de cohorte observationnelle
por: Painvin, B., et al.
Publicado: (2020)

Acquired agitation in acute respiratory distress syndrome with COVID-19 compared to influenza patients: a propensity score matching observational study
por: Maamar, Adel, et al.
Publicado: (2022)

Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study
por: Guillot, Pauline, et al.
Publicado: (2023)

Moderate-to-severe ARDS: COVID-19 patients compared to influenza patients for ventilator parameters and mortality
por: Maamar, Adel, et al.
Publicado: (2023)

Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study
por: Gacouin, Arnaud, et al.
Publicado: (2020)

Inter-hospital transport of critically ill patients to manage the intensive care unit surge during the COVID-19 pandemic in France
por: Painvin, Benoit, et al.
Publicado: (2021)

Hydroxychloroquine lung pharmacokinetics in critically ill patients with COVID-19
por: Ruiz, S., et al.
Publicado: (2021)

Patients with preexisting psychiatric disorders admitted to ICU: a descriptive and retrospective cohort study
por: Gacouin, Arnaud, et al.
Publicado: (2017)

Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients
por: Zahr, Noël, et al.
Publicado: (2022)

Intensive care unit-to-unit capacity transfers are associated with increased mortality: no hasty conclusions in the event of a crisis
por: Painvin, Benoit, et al.
Publicado: (2022)

Herpesviridae systemic reactivation in patients with COVID-19-associated ARDS
por: Reizine, F., et al.
Publicado: (2022)

Pharmacokinetics of baricitinib in critically ill COVID-19 patients
por: Massart, Nicolas, et al.
Publicado: (2023)

Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?
por: Honore, Patrick M., et al.
Publicado: (2019)

Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19
por: Zahr, Noël, et al.
Publicado: (2021)

Severity of illness influences the microcirculatory response to red blood cell transfusion in the critically ill: an observational cohort study
por: van Manen, Lisa, et al.
Publicado: (2020)

Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
por: Cillóniz, Catia, et al.
Publicado: (2023)

Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration
por: Wada, Takeshi, et al.
Publicado: (2015)

Hydroxychloroquine shortage
por: Patel, J., et al.
Publicado: (2020)

Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base
por: Taccone, Fabio S, et al.
Publicado: (2020)

Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
por: Yu, Bo, et al.
Publicado: (2020)

Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?
por: Reizine, Florian, et al.
Publicado: (2021)

Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization
por: Thémans, Pauline, et al.
Publicado: (2020)

Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
por: Garreau, Romain, et al.
Publicado: (2021)

Erratum to: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
por: Yu, Bo, et al.
Publicado: (2020)

Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2
por: MacGowan, Alasdair, et al.
Publicado: (2021)

The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
por: Honore, Patrick M, et al.
Publicado: (2015)

Catecholamine pharmacokinetics and pharmacodynamics in critical illness
por: Johnston, AJ, et al.
Publicado: (2003)

Pharmacokinetics of Micafungin in Critically Ill Patients
por: Gastine, Silke, et al.
Publicado: (2019)

Pharmacokinetics of Esomeprazole in Critically Ill Patients
por: Xu, Yanyan, et al.
Publicado: (2022)

Pharmacokinetic Alterations Associated with Critical Illness
por: Morales Castro, Diana, et al.
Publicado: (2023)

Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study
por: Kevorkian, Jean-Philippe, et al.
Publicado: (2021)

Enteral citrulline supplementation versus placebo on SOFA score on day 7 in mechanically ventilated critically ill patients: the IMMUNOCITRE randomized clinical trial
por: Tadié, Jean-Marc, et al.
Publicado: (2023)

Insulin and the critically ill
por: Das, Undurti N
Publicado: (2002)

Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters
por: Weiss, Johanna, et al.
Publicado: (2020)

Upper and lower limb muscle atrophy in critically ill patients: an observational ultrasonography study
por: Nakanishi, Nobuto, et al.
Publicado: (2017)

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19
por: Irie, Kei, et al.
Publicado: (2020)

Pharmacokinetics of enoxaparin in COVID-19 critically ill patients
por: Zufferey, Paul Jacques, et al.
Publicado: (2021)

Gastrointestinal failure score in critically ill patients
por: Berger, Mette M, et al.
Publicado: (2008)

Population Pharmacokinetics of Hydroxychloroquine and 3 Metabolites in COVID-19 Patients and Pharmacokinetic/Pharmacodynamic Application
por: Alvarez, Jean Claude, et al.
Publicado: (2022)

Perceived efficacy of hydroxychloroquine in observational studies: Results of the confounding effect of “goals of care”
por: Tleyjeh, Prof. Imad M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qcn58sq65jpi2eonj9kp4igrt7